About
Catherine Owen Adams has served on Agios's board since June 2023 and has been chief executive officer and a director of Acadia Pharmaceuticals since September 2024.
She was previously senior vice president, major markets at Bristol-Myers Squibb, overseeing commercial operations across 18 countries, and earlier held senior commercial roles at Johnson & Johnson, including president of Janssen Immunology North America. She earned a bachelor of science in pharmacy from the University of Manchester.
Roles
Agios Pharmaceuticals, Inc.
Director · Current role
Jun 2023–present
Bristol-Myers Squibb
SVP, Major Markets · Oversaw commercial operations across 18 countries; joined BMS in 2019.
—
Johnson & Johnson
President, Janssen Immunology North America
2018 – 2019
Johnson & Johnson
President, Infectious Diseases (US)
2016 – 2018
AstraZeneca
Production support pharmacist · Began pharmaceutical-industry career in 1992 in London.
—
External Roles
Acadia Pharmaceuticals
Chief Executive Officer and Board of Directors
—
AssistRx
Board of Directors
—
Optinose PLC
Board of Directors and Chair of the Compensation Committee
—
Director Compensation
FY 2025
Fees earned or paid in cash
$58,750
Also at Agios Pharmaceuticals, Inc.